LifeScience Biologics

Thermo Fisher Scientific Partners PRECISE To Advance Singapore’s Landmark SG100K Biobank Study

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,  announced a strategic collaboration with Precision Health Research, S...

 April 10, 2026 | News

Biocon Limited Launches Bosaya And Aukelso In The United States To Expand Bone Health Access

Bosaya™ and Aukelso™ (both denosumab-kyqq products) now available in the United States, following U.S. FDA approval in September 2025 with ...

 April 10, 2026 | News

Ascletis Pharma Inc. Advances Oral GLP 1 And Amylin Combination For Obesity Treatment

-Fixed-dose combination of ASC30 and ASC39 (ASC30_39 FDC) tablets, dosed orally in dogs, demonstrated comparable pharmacokinetics to those observed in...

 April 09, 2026 | News

TriNetX Acquires Zetta Genomics Assets To Strengthen Multiomic Data Capabilities

TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient c...

 April 09, 2026 | News

Singlomics Biopharmaceuticals Doses First Patient In Phase I Trial Of DXP 106 Antibody

Singlomics Biopharmaceuticals, an innovative clinical-stage biopharmaceutical company focused on the discovery and development of antibody therapeutics for...

 April 09, 2026 | News

Everest Medicines To Acquire Hasten Biopharmaceuticals Singapore Unit In USD 250 Million Deal

Accelerates Asia Pacific expansion by acquiring a ready-built regional commercial platform with 14 marketed chronic disease products Aggregate considera...

 April 09, 2026 | News

ATLATL And Daiichi Sankyo Partner To Advance APAC Driven Biopharma Innovation

ATLATL Innovation Center (hereinafter referred to as "ATLATL"), a global innovation platform for life science research and development, announced an agreem...

 April 09, 2026 | News

Amgen Reports Strong Phase 3 Results For Subcutaneous TEPEZZA In Thyroid Eye Disease

Primary and Key Secondary Endpoints Met 77% of Patients Achieved Highly Statistically Significant Proptosis Response Study Showed Clinically Meaningful R...

 April 08, 2026 | News

Perceptive Discovery Expands In Vitro Capabilities To Accelerate Oncology Drug Development

Perceptive Discovery, a leading scientific partner to the global biopharmaceutical industry, announced a major expansion of its in vitro laboratory capabil...

 April 07, 2026 | News

Neurocrine Biosciences To Acquire Soleno Therapeutics For $2.9 Billion To Strengthen Rare Disease Portfolio

VYKAT™ XR (diazoxide choline) is the First and Only FDA Approved Treatment for Hyperphagia in Prader-Willi Syndrome and...

 April 07, 2026 | News

GC Biopharma Reports Proprietary Analytical Method For Precise Factor XI Measurement In Journal of Microbiology and Biotechnology

Proprietary analytical method for precise Factor XI (FXI) measurement published in the Journal of Microbiology and Biotechnology Novel IgG B...

 April 07, 2026 | News

Alphamab Oncology Reports Phase III Success For Anbenitamab In HER2 Positive Breast Cancer

Alphamab Oncology  announced that HER2 bispecific antibody Anbenitamab Injection (KN026), independently developed by the Company, and co-developed wit...

 April 06, 2026 | News

Earendil Labs Advances HXN 1001 With First Patient Dosed In Phase IIa Ulcerative Colitis Trial

Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics,  announced the first patient has been dosed in a Phase IIa clin...

 April 06, 2026 | News

Regeneron And TriNetX Partner To Expand Global Genomic And EHR Linked Data Platform

Regeneron has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX's industry-leading global network of electronic he...

 April 06, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close